Have you checked out our newsletter?
Stay ahead with expert insights, strategic tips, and industry trends—all designed to boost your brand's med comm initiatives.
"*" indicates required fields
Get fresh insights and candid perspectives on timely issues impacting the pharmaceutical industry from our blog.
The Latest News
Virtual Speaker Programs for Busy Providers
The Biggest Challenge Is Not Lack of Information In the current healthcare environment, new drugs are being approved by the FDA daily. Imagine a healthcare provider who sees a patient recently diagnosed with obesity and is looking to start a weight-loss program. The physician has a busy practice. She often finds it time-consuming
Industry Insights – May 2026
Biosimilars are gaining U.S. momentum even as patent thickets keep triggering legal fights, small biotechs are feeling the pressure of the FDA’s faster-moving approval environment, and the agency is testing real-time clinical trial review with big-name drugmakers already on board. It’s a fast-changing drug-development landscape worth watching. Don’t miss the
BioPharma in the News – April 2026
The FDA is escalating its ongoing push for transparency and tougher enforcement, including publicizing complete response letters, seeking new authority over DTC drug advertising, and tightening expectations around external controls in rare disease trials. Don’t miss the latest in the industry. Source: PharmaVoice The FDA’s push for “radical transparency” is
When the Universe Has Other Plans: How to Save a Speaker Program in Crisis
It’s the perfect storm: TSA staffing shortages, extreme weather, constant flight delays, and airlines cutting hundreds of flights daily1. There is an in-person speaker program tonight. Your scheduled speaker wakes up to a ping on his phone at 4:30 am and finds the dreaded message: “We have been notified by
What’s Trending in BioPharma – March 2026
Europe risks falling behind in the global BioPharma race, the FDA is working to increase accessibility to personalized treatments in rare diseases, and regulators are cracking down on unapproved compounded GLP-1 weight loss drugs. Together, these three stories show the shifting landscape of innovation, regulation, and competition shaping the BioPharma
What’s Trending in BioPharma – February 2026
The BioPharma industry is in rapid flux, shaped by transforming drug pipelines, the ongoing political battle over lowering drug prices, and a new rebate model for the 340B Drug Discount program. Here’s what’s shaping the latest in healthcare. Source: BioPharma International In a recent BioPharm International interview, Janice MacLennan, founder
Launch Broadcast? Yes! Mid Product Life-Cycle? ABSOLUTELY!
One of the most persistent myths about broadcasts is that they are only good for new product launches. The reality is that while product launches are indeed a great time to deploy wide-reaching national broadcasts, their utility extends far beyond this single use. National broadcasts are perfect for announcing newly
What’s Trending in BioPharma – January 2026
The BioPharma industry is in rapid flux, shaped by rising tariffs, shifting policies, and new barriers to prescription access. Here’s a quick look at the forces driving change. Source: BioSpace The biopharma sector is entering 2026 with renewed strength following a market rebound. Analysts point to oncology, neuroscience, and immunology
V2V Wins 2025 International Torch Award
Vision2Voice Healthcare Communications is honored to be named one of five winners of the 2025 BBB International Torch Awards for Ethics! V2V has previously been awarded in the USA at the regional level on five previous occasions, but this recognition marks our first on the international stage. For over a decade,